UA42806C2 - Система для одночасного трансдермального введення кількох активних начал - Google Patents

Система для одночасного трансдермального введення кількох активних начал

Info

Publication number
UA42806C2
UA42806C2 UA97062931A UA97062931A UA42806C2 UA 42806 C2 UA42806 C2 UA 42806C2 UA 97062931 A UA97062931 A UA 97062931A UA 97062931 A UA97062931 A UA 97062931A UA 42806 C2 UA42806 C2 UA 42806C2
Authority
UA
Ukraine
Prior art keywords
active agents
introduction
therapeutic dose
effective therapeutic
several active
Prior art date
Application number
UA97062931A
Other languages
English (en)
Russian (ru)
Inventor
Бруно Беван
Сесіль Айо
Сесиль Ае
Original Assignee
Лаборатуар Д'Іжьєн Е Де Дьєтетік
Лаборатуар Д'Ижьен э Де Дьететик
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Д'Іжьєн Е Де Дьєтетік, Лаборатуар Д'Ижьен э Де Дьететик filed Critical Лаборатуар Д'Іжьєн Е Де Дьєтетік
Publication of UA42806C2 publication Critical patent/UA42806C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Система для черезшкірного введення включає перший засіб з сумішшю всіх активних агентів. Один перший активний агент міститься у кількості, що забезпечує ефективну терапевтичну дозу, що потрібно ввести. Другий активний агент міститься у кількості, яка менша потрібної для введення ефективної терапевтичної дози. Система також включає один або декілька додаткових засобів. Кожен з них містить один активний агент (В), що вибраний з присутніх у першому засобі. Всі вони знаходяться в кількості, яка менша тієї кількості, яка потрібна для одержання ефективної терапевтичної дози. Вказаний додатковий засіб чи засоби доставляють кожний з активних агентів, що містяться в системі у кількості, що необхідна для отримання ефективної терапевтичної дози.
UA97062931A 1994-12-21 1995-12-19 Система для одночасного трансдермального введення кількох активних начал UA42806C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415416A FR2728463A1 (fr) 1994-12-21 1994-12-21 Systeme transdermique d'administration simultanee de plusieurs principes actifs
PCT/FR1995/001696 WO1996019203A1 (fr) 1994-12-21 1995-12-19 Systeme transdermique d'administration simultanee de plusieurs principes actifs

Publications (1)

Publication Number Publication Date
UA42806C2 true UA42806C2 (uk) 2001-11-15

Family

ID=9470067

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97062931A UA42806C2 (uk) 1994-12-21 1995-12-19 Система для одночасного трансдермального введення кількох активних начал

Country Status (24)

Country Link
US (1) US5919477A (uk)
EP (1) EP0800386B1 (uk)
JP (1) JPH10510823A (uk)
KR (1) KR980700071A (uk)
CN (1) CN1072929C (uk)
AT (1) ATE173164T1 (uk)
AU (1) AU692042B2 (uk)
CA (1) CA2208374A1 (uk)
CZ (1) CZ183297A3 (uk)
DE (1) DE69506007T2 (uk)
DK (1) DK0800386T3 (uk)
ES (1) ES2125679T3 (uk)
FI (1) FI972542A (uk)
FR (1) FR2728463A1 (uk)
HK (1) HK1004375A1 (uk)
HU (1) HUT77384A (uk)
NO (1) NO972467L (uk)
NZ (1) NZ298826A (uk)
PL (1) PL182452B1 (uk)
RU (1) RU2157193C2 (uk)
SI (1) SI0800386T1 (uk)
SK (1) SK280631B6 (uk)
UA (1) UA42806C2 (uk)
WO (1) WO1996019203A1 (uk)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2179646T3 (es) 1998-04-27 2003-01-16 Surmodics Inc Revestimiento que libera un agente bioactivo.
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US7243788B2 (en) * 2003-10-22 2007-07-17 Kimberly-Clark Worldwide, Inc. Package for segregating and mixing substances
ES2626784T3 (es) * 2003-10-28 2017-07-26 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos
US7541048B2 (en) 2004-04-06 2009-06-02 Surmodics, Inc. Coating compositions for bioactive agents
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス，インコーポレイテッド 創傷充填デバイスおよび方法
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator

Also Published As

Publication number Publication date
US5919477A (en) 1999-07-06
AU4450596A (en) 1996-07-10
EP0800386B1 (fr) 1998-11-11
HUT77384A (hu) 1998-04-28
CN1072929C (zh) 2001-10-17
AU692042B2 (en) 1998-05-28
FR2728463B1 (uk) 1997-02-21
FR2728463A1 (fr) 1996-06-28
HK1004375A1 (en) 1998-11-27
MX9704527A (es) 1997-10-31
SI0800386T1 (en) 1999-04-30
PL320883A1 (en) 1997-11-10
WO1996019203A1 (fr) 1996-06-27
CA2208374A1 (en) 1996-06-27
RU2157193C2 (ru) 2000-10-10
SK280631B6 (sk) 2000-05-16
CN1170359A (zh) 1998-01-14
FI972542A0 (fi) 1997-06-16
NZ298826A (en) 1998-10-28
DE69506007D1 (de) 1998-12-17
PL182452B1 (pl) 2002-01-31
DE69506007T2 (de) 1999-06-10
DK0800386T3 (da) 1999-07-26
CZ183297A3 (en) 1997-10-15
KR980700071A (ko) 1998-03-30
JPH10510823A (ja) 1998-10-20
ES2125679T3 (es) 1999-03-01
NO972467D0 (no) 1997-05-30
EP0800386A1 (fr) 1997-10-15
NO972467L (no) 1997-06-17
FI972542A (fi) 1997-06-16
SK79197A3 (en) 1997-12-10
ATE173164T1 (de) 1998-11-15

Similar Documents

Publication Publication Date Title
UA42806C2 (uk) Система для одночасного трансдермального введення кількох активних начал
IE882954L (en) Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
CU23126A3 (es) Inhibicion de kinasa raf usando ureas heterociclicas sustituidas
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
MX9704640A (es) Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion.
DE3872059D1 (de) Verfahren und vorrichtungen, um duftstoffe zu verteilen.
NO20003534D0 (no) Progesteronreseptor-modulatorforbindelser, farmasøytiske sammensetninger inneholdende disse og anvendelsen av forbindelsene
CY2473B1 (en) New phenanthridines.
EP0991618A4 (en) SELECTIVE ANALOGS OF THYROID HORMONES
IL124109A0 (en) 2-alkylpyrrolidines
BR9305783A (pt) Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
GR3033894T3 (en) Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-alpha and histamine, serotonin or substances with corresponding receptor activity.
GR3030919T3 (en) Selective system scan for multizone radiotelephone subscriber units.
MY102046A (en) Compartmentalized transdermal delivery system.
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
HUT65732A (en) Process for producing peptide compounds first of all lhrh antagonists
HUT41002A (en) Process for preparing anticonvulsives
WO1995016709A3 (en) Anti-mullerian hormone receptor polypeptides and antibodies thereto
PT83253A (en) Process for preparing p-acylaminobenzamides
SU1240038A1 (ru) 3-оксиэстра-1,3,5-триен-17-гидразон, обладающий гормональной и противоопухолевой активностью
IL128768A0 (en) Transdermal therapeutic system containing oestriol
JO1179B1 (en) Kinolone compounds have therapeutic activity. Therapeutic formulations containing quinolones and methods of preparation.